HER2CLIMB
E2190195
UNEXPLORED
HER2CLIMB is a pivotal clinical trial that evaluated the efficacy and safety of tucatinib in combination therapy for patients with HER2-positive breast cancer, including those with brain metastases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| HER2CLIMB canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.